Predict your next investment


See what CB Insights has to offer


Merger | Merged



About IDEC Pharmaceuticals

Producer of antibody-based treatment for lymphoma. The company completed an IPO and later merged with Biogen (Nasdaq: BIIB).

IDEC Pharmaceuticals Headquarter Location

Corporate Headquarters 14 Cambridge Center

Cambridge, Massachusetts, 02142,

United States

Latest IDEC Pharmaceuticals News

Arix Bioscience appoints biopharma veteran as venture partner

Mar 30, 2021

Dittmar has over 20 years of experience in the biotechnology sector with direct operating experience in the US, Europe and the Middle East, the venture capital company said. She served in multiple roles of increasing responsibility in the areas of corporate and business development with IDEC Pharmaceuticals, Biogen Inc., Dance Biopharm (now Aerami Therapeutics), and most recently Ethris GmbH, where she was appointed chief executive from 2018 to 2020. from Occidental College, and has authored primary research in the areas of immunology and lymphocyte signalling. "I am delighted to welcome Gita to the team,” said Naseem Amin, executive chairman of Arix, in a release. “Her experience in evaluating and executing late-stage investments for Pharmaceutical companies on the corporate development side, coupled with her expertise in early-stage company building, will be of great benefit to Arix's Investment team as we continue to build and support our existing investments and leverage our extensive pipeline of new opportunities in both early and late-stage assets." Quick facts: Arix Bioscience PLC Price: 190.8 GBX

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing IDEC Pharmaceuticals

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

IDEC Pharmaceuticals is included in 1 Expert Collection, including Smart Money VCs (2017-2019).


Smart Money VCs (2017-2019)

6,297 items

We crunched the data to identify the 24 VC firms with the best combination of portfolio valuations and investment outcomes.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.